Bausch + Lomb Corp
BLCO
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.84B
Close$
$-1.74
110.1% downside
Current Fair Value
110.1% downsideOvervalued by 110.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.84 Billion |
|---|---|
| Enterprise Value | $8.51 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.02 |
| Beta | 0.56 |
| Outstanding Shares | 357,100,000 |
Return
| Return on Equity | -2.62% |
|---|---|
| Return on Assets | -1.20% |
| Return on Invested Capital | 3.32% |
Valuation & Multiples
| P/E Ratio | -36.18 |
|---|---|
| PEG | 37.78 |
| Price to Sales | 1.23 |
| Price to Book Ratio | 0.95 |
| Enterprise Value to Revenue | 1.6 |
| Enterprise Value to EBIT | 21.44 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$0.15
Average shareholder expectationRevenue Estimate
$1.37 B
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$0.21
Average shareholder expectationRevenue Estimate
$1.37 B
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 9.12% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.04%▼ 10.66% |
|---|---|
| Total Invested | $2.19M▼ 99.65% |
| Investors Holding | 7▼ 95.00% |
ESG Score
No data
About Bausch + Lomb Corp
13,000 employees
CEO: Brenton L. Saunders Bausch + Lomb Corporation is a global leader in eye health, delivering a wide range of products and services across the world. Its business is divided into three key areas: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, an...